AnaptysBio financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

어냅티스바이오NASDAQ:ANAB · Nasdaq · Healthcare

$48.53-0.21%

2026-10-02 close

AnaptysBio's published financial data is dated 2026-10-04. 2024 revenue was $91M. 2024 operating profit was −$115M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy